Dr. Groteluschen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1726 Shawano Ave
Green Bay, WI 54303Phone+1 920-884-3135Fax+1 920-884-3144
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2004 - 2006
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2001 - 2004
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001
Certifications & Licensure
- MI State Medical License 2006 - 2025
- WI State Medical License 2002 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 109 citationsVorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II StudyAnne M. Traynor, Sarita Dubey, Jens C. Eickhoff, Jill M. Kolesar, Kathleen Schell
Journal of Thoracic Oncology. 2009-04-01 - 7 citationsA phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.Rory Joseph Makielski, Sam J. Lubner, Daniel Mulkerin, Anne M. Traynor, David Groteluschen
Cancer Chemotherapy and Pharmacology. 2015-06-12 - 40 citationsA phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg, William J. Maples, David L. Groteluschen
Gynecologic Oncology. 2012-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: